Saito, T.; Saito, M.; Yamamoto, R.; Sagehashi, R.; Aoyama, Y.; Mori, M.; Kajiwara, C.; Furihata, K.; Kagaya, H.; Yagishita, H.;
et al. Everolimus-Involving Immunosuppression Attenuates Renal Interstitial Fibrosis Through Modulation of Mammalian Target of Rapamycin-Related Signal Transduction. Int. J. Mol. Sci. 2026, 27, 7634.
https://doi.org/10.3390/ijms27177634
AMA Style
Saito T, Saito M, Yamamoto R, Sagehashi R, Aoyama Y, Mori M, Kajiwara C, Furihata K, Kagaya H, Yagishita H,
et al. Everolimus-Involving Immunosuppression Attenuates Renal Interstitial Fibrosis Through Modulation of Mammalian Target of Rapamycin-Related Signal Transduction. International Journal of Molecular Sciences. 2026; 27(17):7634.
https://doi.org/10.3390/ijms27177634
Chicago/Turabian Style
Saito, Takuro, Mitsuru Saito, Ryohei Yamamoto, Ryuichiro Sagehashi, Yu Aoyama, Mizuki Mori, Chika Kajiwara, Kengo Furihata, Hideaki Kagaya, Hironobu Yagishita,
and et al. 2026. "Everolimus-Involving Immunosuppression Attenuates Renal Interstitial Fibrosis Through Modulation of Mammalian Target of Rapamycin-Related Signal Transduction" International Journal of Molecular Sciences 27, no. 17: 7634.
https://doi.org/10.3390/ijms27177634
APA Style
Saito, T., Saito, M., Yamamoto, R., Sagehashi, R., Aoyama, Y., Mori, M., Kajiwara, C., Furihata, K., Kagaya, H., Yagishita, H., Fujiyama, N., Kashima, S., Numakura, K., Narita, S., Kikuchi, M., Miura, M., & Habuchi, T.
(2026). Everolimus-Involving Immunosuppression Attenuates Renal Interstitial Fibrosis Through Modulation of Mammalian Target of Rapamycin-Related Signal Transduction. International Journal of Molecular Sciences, 27(17), 7634.
https://doi.org/10.3390/ijms27177634
